Commodore Capital LP Q2 2023 Filing
Filed August 14, 2023
Portfolio Value
$889.8B
Holdings
26
Report Date
Q2 2023
Filing Type
13F-HR
All Holdings (26 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | MRUSMERUS N V | 4,000,000 | $105K | 0.00% | |
| 2 | VERAVERA THERAPEUTICS INC | 5,450,000 | $87K | 0.00% | |
| 3 | AKROAKERO THERAPEUTICS INC | 1,675,000 | $78K | 0.00% | |
| 4 | XENEXENON PHARMACEUTICALS INC | 1,845,000 | $71K | 0.00% | |
| 5 | COGTCOGENT BIOSCIENCES INC | 5,566,026 | $65K | 0.00% | |
| 6 | —AMBRX BIOPHARMA INC | 3,175,000 | $52K | 0.00% | |
| 7 | VRDNVIRIDIAN THERAPEUTICS INC | 2,200,000 | $52K | 0.00% | |
| 8 | PCVXVAXCYTE INC | 1,015,000 | $50K | 0.00% | |
| 9 | NUVLNUVALENT INC | 1,150,000 | $48K | 0.00% | |
| 10 | ELVNENLIVEN THERAPEUTICS INC | 2,348,272 | $47K | 0.00% | |
| 11 | CABACABALETTA BIO INC | 2,368,186 | $30K | 0.00% | |
| 12 | CBAYUSDCYMABAY THERAPEUTICS INC | 2,025,000 | $22K | 0.00% | |
| 13 | ARWRARROWHEAD PHARMACEUTICALS IN | 610,000 | $21K | 0.00% | |
| 14 | TCE2CELLDEX THERAPEUTICS INC NEW | 631,665 | $21K | 0.00% | |
| 15 | SNDXSYNDAX PHARMACEUTICALS INC | 997,596 | $20K | 0.00% | |
| 16 | IDYAIDEAYA BIOSCIENCES INC | 775,000 | $18K | 0.00% | |
| 17 | IMVTIMMUNOVANT INC | 900,000 | $17K | 0.00% | |
| 18 | CELCCELCUITY INC | 1,444,141 | $15K | 0.00% | |
| 19 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 10,000,000 | $15K | 0.00% | |
| 20 | KURAKURA ONCOLOGY INC | 1,400,000 | $14K | 0.00% | |
| 21 | NVLSEURALPINE IMMUNE SCIENCES INC | 1,325,000 | $13K | 0.00% | |
| 22 | DAWNDAY ONE BIOPHARMACEUTICALS I | 739,661 | $8K | 0.00% | |
| 23 | THRDTHIRD HARMONIC BIO INC | 993,294 | $4K | 0.00% | |
| 24 | KALVKALVISTA PHARMACEUTICALS INC | 312,553 | $2K | 0.00% | |
| 25 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 2,908,100 | $1K | 0.00% | |
| 26 | —DBV TECHNOLOGIES S A | 92,687 | $0 | 0.00% |